ScripBiopharmaceutical companies celebrated recent positive data readouts with a slew of significant follow-on public offerings (FOPOs), including Nuvalent, Inc. , which grossed $500m on 16 September from
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Coya And Dr Reddy’s Ink Deal For C
ScripAmid a longer than expected industry downturn, Chinese pharma firms with a solid commercial footing in their home market are now turning to acquiring domestic rights to novel drug assets from their bi
ScripSome 10 years after its founding, China- and US-based Connect Biopharma Holdings Ltd. is readying a major regulatory filing for its lead candidate, a novel anti-interleukin 4 receptor alpha antibody